51 – 60 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
(
- Contribution to journal › Article
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
-
Mark
Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.
(
- Contribution to journal › Article
-
Mark
Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.
(
- Contribution to journal › Article
-
Mark
THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: 'DO NOT THROW THE BABY OUT WITH THE BATH WATER'
(
- Contribution to journal › Article
-
Mark
Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Non-genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue
(
- Contribution to journal › Article
-
Mark
Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
(
- Contribution to journal › Article
-
Mark
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
(
- Contribution to journal › Article